Wako, 122-05191, Lipopolysaccharide, from E.coli O127 (by ultracentrifugation)

A component of the outer membrane of gram-negative bacteria. It exhibits various biological activities including adjuvant effect, mitogen activity, platelet and leukocyte decrease, and pyrexia as an endotoxin. It stimulates the release of IL-1, IL-6, IL-8, IFN-alpha/beta, and CSF., Cell Biological Research, Research on Biological Defense Mechanism, LPS is the major component of the outer membrane of Gram-negative bacteria., Products prepared by isolating rough LPS from, E. coli, by phenol-water extraction (Westphal method) (product purified by phenol extraction) and products purified by ultracentrifugation and washed twice (product purified by ultracentrifugation) are available., These can be used for studies on the induction of various inflammatory responses., [Source], E. coli, [Appearance], Lyophilized, Product List, Lipopolysaccharide (by phenol extraction) from, E. coli, O26 (Wako Cat.#120-05131 (25mg)), Lipopolysaccharide (by phenol extraction) from, E. coli, O55 (Wako Cat.#127-05141 (25mg)), Lipopolysaccharide (by phenol extraction) from, E. coli, O127 (Wako Cat.#124-05151 (25mg)), Lipopolysaccharide (by ultracentrifugation) from, E. coli, O26 (Wako Cat.#121-05161 (5mg)), Lipopolysaccharide (by ultracentrifugation) from, E. coli, O55 (Wako Cat.#128-05171 (5mg)), Lipopolysaccharide (by ultracentrifugation) from, E. coli, O111 (Wako Cat.#125-05181 (5mg)), This product is for research use only. Do not administer it to human.